Global Lamotrigine
Market Report
2025
lamotrigine market size is USD XX million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.
The base year for the calculation is 2024 and 2021 to 2024 will be historical period. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Lamotrigine Market Report 2024.
According to Cognitive Market Research, the global lamotrigine market size is USD XX million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.
2019 | 2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|---|
Global Lamotrigine Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 121212 | 5% |
North America Lamotrigine Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 121212 | 3.2% |
Europe Lamotrigine Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 121212 | 3.5% |
Asia Pacific Lamotrigine Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 121212 | 7% |
South America Lamotrigine Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 121212 | 4.4% |
Middle East and Africa Lamotrigine Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 121212 | 4.7% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
Market Split by Distribution |
|
Market Split by End User |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Lamotrigine industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Lamotrigine Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Lamotrigine is a pharmaceutical compound primarily used as an anticonvulsant and mood stabilizer. Marketed under various brand names, it is commonly prescribed for the treatment of epilepsy, specifically as adjunctive therapy in partial seizures, generalized seizures of the tonic-clonic type, and Lennox-Gastaut syndrome. Additionally, lamotrigine is utilized in the management of bipolar disorder to mitigate manic and depressive episodes. Its mechanism of action involves modulation of voltage-gated sodium channels, thereby stabilizing neuronal membranes and inhibiting excessive excitability. Despite its efficacy, lamotrigine carries potential side effects including skin rash, headache, dizziness, and gastrointestinal disturbances, necessitating careful monitoring during administration.
The expanding geriatric population is poised to increase sales in the lamotrigine market. With age, individuals become more susceptible to neurological and mood disorders such as epilepsy and bipolar disorder. As the elderly demographic grows globally, there's a corresponding rise in the prevalence of these conditions. Healthcare providers are increasingly prescribing lamotrigine to manage these disorders in older adults due to its proven efficacy and tolerability profile. Consequently, pharmaceutical companies catering to this demographic stand to benefit from heightened demand for lamotrigine, driving sales upward as the geriatric population continues to expand.
In December 2022, GSK announced that its new global headquarters will be in central London. The site which is under construction and scheduled for completion next year, was selected by the company following a comprehensive search of potential new HQ sites across London. It offers close proximity to the UK capital’s fast-growing global Life Sciences hub, London’s Knowledge Quarter, and GSK’s existing collaboration partners including the Francis Crick Institute and King’s College London.
The growing prevalence of epilepsy and bipolar disorder is a significant driver fuelling the sales of lamotrigine in the pharmaceutical market. Epilepsy affects millions worldwide, with increasing incidence rates observed in both developed and developing regions. Similarly, bipolar disorder, characterized by manic and depressive episodes, is also on the rise, impacting individuals across diverse demographics. As awareness campaigns and diagnostic capabilities improve, more cases of these conditions are being identified, leading to a higher demand for effective treatments like lamotrigine. Additionally, factors such as aging populations, lifestyle changes, and genetic predispositions contribute to the increasing prevalence of these disorders. Consequently, pharmaceutical companies are poised to witness continued growth in sales of lamotrigine as it remains a cornerstone in the management of epilepsy and bipolar disorder amidst these escalating healthcare challenges.
The increasing acceptance and adoption of pharmacological interventions are key drivers propelling the growth of the lamotrigine market. As societal attitudes toward mental health continue to evolve, there's a greater acknowledgment of neurological and mood disorders, leading to a reduced stigma associated with seeking treatment. Moreover, advancements in medical research and technology have bolstered confidence in pharmacological solutions among healthcare providers and patients alike. Lamotrigine, known for its efficacy in managing epilepsy and bipolar disorder, benefits from this trend toward pharmacotherapy. Additionally, as patients become more informed about treatment options and the importance of medication adherence, there's a growing preference for pharmaceutical interventions over alternative therapies. This increasing acceptance and adoption of pharmacological interventions create a conducive environment for the sustained growth of the lamotrigine market, driving sales upward in the foreseeable future.
Concerns regarding potential side effects pose a significant restraint on the growth of the lamotrigine market. While lamotrigine is generally well-tolerated, there are risks of adverse reactions, including skin rash, headaches, dizziness, and gastrointestinal disturbances. Severe adverse effects such as Stevens-Johnson syndrome and toxic epidermal necrolysis have also been reported, albeit rare. These safety concerns contribute to hesitancy among healthcare providers and patients, impacting prescription rates and adherence to treatment regimens. Furthermore, media coverage and patient forums amplify these concerns, influencing public perception and decision-making regarding medication choices. Pharmaceutical companies must address these safety concerns through rigorous monitoring, risk mitigation strategies, and transparent communication to healthcare professionals and patients. Failure to do so may result in decreased market uptake and potential regulatory scrutiny, limiting the overall growth prospects of lamotrigine.
The COVID-19 pandemic inflicted a negative impact on the lamotrigine market. Lockdown measures, disrupted supply chains, and overwhelmed healthcare systems led to delays in patient consultations, diagnoses, and treatment initiation. Additionally, economic uncertainties prompted some patients to forgo or reduce their medication usage to cut costs. The shift in healthcare priorities towards managing the pandemic further diverted attention and resources away from chronic conditions like epilepsy and bipolar disorder. Moreover, clinical trials for new formulations or indications of lamotrigine may have been delayed or suspended, impeding innovation and market expansion efforts. Overall, the pandemic-induced disruptions exacerbated existing challenges in the lamotrigine market, resulting in reduced sales and dampened growth prospects in the short to medium term.
We have various report editions of Lamotrigine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The competitive landscape of the lamotrigine market is characterized by diverse players vying for market share. Companies compete based on product efficacy, safety, pricing strategies, and distribution networks. Intense competition fosters innovation and drives efforts to differentiate offerings in this vital pharmaceutical segment.
Top Companies Market Share in Lamotrigine Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue driven by several factors. Firstly, the region boasts advanced healthcare infrastructure and high levels of diagnosis rates for neurological and mood disorders. Additionally, rising awareness campaigns and de-stigmatization efforts surrounding mental health encourage more individuals to seek treatment. Moreover, robust research and development activities continually improve lamotrigine formulations, enhancing efficacy and patient outcomes. Lastly, favourable reimbursement policies and insurance coverage contribute to increased affordability and accessibility, further boosting sales in the region.
The Asia-Pacific is the fastest growing region due to various factors. Firstly, the region's expanding population, particularly in urban areas, leads to a higher incidence of epilepsy and bipolar disorder diagnoses. Secondly, increasing healthcare expenditure and infrastructure development improve access to medications, driving demand. Thirdly, growing awareness campaigns and advocacy efforts enhance understanding of mental health issues, encouraging treatment-seeking behaviour. Moreover, partnerships and collaborations between pharmaceutical companies and local healthcare providers facilitate market penetration.
The current report Scope analyzes Lamotrigine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global lamotrigine market size was estimated at USD XX Million out of which North America held the major market of around 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031. In North America, the sales of lamotrigine are poised to increase due to robust healthcare infrastructure and high diagnosis rates. Moreover, favourable reimbursement policies and insurance coverage enhance affordability and accessibility. Additionally, the region's aging population drives demand for treatments targeting neurological and mood disorders. Furthermore, increasing mental health awareness fosters treatment-seeking behaviour among patients. With its proven efficacy, lamotrigine is well-positioned to cater to the growing demand, particularly in hospital pharmacies. Its dominance in the epilepsy segment is further strengthened by the prevalence of the disorder and the established trust among healthcare professionals for its management.
Country Analysis
According to Cognitive Market Research, with a market value of USD xx million in 2024 out of which Europe held the major market of around 30% of the global revenue with a market size of USD xx million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031. Europe anticipates rising sales of lamotrigine owing to expanding healthcare expenditure and infrastructure. Additionally, initiatives promoting mental health awareness encourage treatment-seeking behaviour among the populace. Moreover, the presence of leading pharmaceutical companies fosters innovation and market growth. Furthermore, stringent regulatory standards ensure the quality and safety of medications, enhancing consumer confidence. Within the region, hospital pharmacies hold a major market share, benefiting from their established distribution networks and trusted relationships with healthcare providers. The dominance of lamotrigine in this segment is reinforced by its efficacy in managing epilepsy, a prevalent neurological condition in Europe.
According to Cognitive Market Research, the global lamotrigine market size was estimated at USD XX Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031. The Asia Pacific region sees increasing sales of lamotrigine due to rising healthcare expenditure and improving access to healthcare services. Furthermore, growing awareness campaigns about neurological and mood disorders drive diagnosis rates and treatment-seeking behaviour. Additionally, advancements in telemedicine and e-prescription systems facilitate medication procurement. Moreover, the region's large paediatric population contributes to the growth of lamotrigine sales, particularly in the fastest-growing segment of paediatric epilepsy. Its efficacy and tolerability in children make it a preferred choice among healthcare providers, further solidifying its market position in the region.
According to Cognitive Market Research, the global lamotrigine market size was estimated at USD XX Million out of which Latin America market of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031. Latin America experiences growing sales of lamotrigine fuelled by expanding healthcare infrastructure and rising awareness about mental health. Furthermore, increasing urbanization and access to healthcare services drive diagnosis rates for neurological disorders. Additionally, the region's aging population contributes to the demand for treatments targeting mood disorders. Moreover, partnerships between pharmaceutical companies and healthcare organizations enhance market penetration. Within Latin America, the fastest-growing segment of bipolar disorder sees a surge in demand for lamotrigine. Its effectiveness in stabilizing mood swings positions it as a key medication in managing the disorder, further propelling its sales in the region.
According to Cognitive Market Research, the global Lamotrigine market size was estimated at USD XX Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031. In the MEA region, sales of lamotrigine are on the rise due to improving healthcare infrastructure and rising healthcare spending. Additionally, increasing awareness about neurological disorders among the population drives demand for effective treatments like lamotrigine. Moreover, partnerships between pharmaceutical companies and local healthcare providers enhance accessibility to medications. Furthermore, the region's growing geriatric population contributes to the demand for treatments targeting neurological and mood disorders. Within MEA, the dominance of lamotrigine in hospital pharmacies is strengthened by its efficacy in managing epilepsy, a prevalent neurological condition in the region.
Global Lamotrigine Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Lamotrigine Industry growth. Lamotrigine market has been segmented with the help of its Type, Application Distribution, and others. Lamotrigine market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, purity 98%-99% held the major market share over the forecast period due to its established reputation for reliability and efficacy among healthcare providers. Additionally, as regulatory bodies emphasize the importance of quality standards, pharmaceutical companies prioritize the production of high-purity formulations, driving demand for this category. Moreover, patients and healthcare professionals alike prefer standardized formulations with predictable therapeutic outcomes, further bolstering sales in this segment.
Purity 99% is the fastest-growing category over the forecast period due to increasing demand for highly purified pharmaceuticals with minimal impurities. This category is favoured for its superior quality and potency, appealing to healthcare providers seeking optimal treatment options for their patients. Additionally, advancements in manufacturing technologies enable the production of higher purity formulations, further driving growth. Moreover, as patients become more discerning about the quality of medications they consume, there is a growing preference for Purity 99% lamotrigine, propelling its sales forward.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Lamotrigine Industry. Request a Free Sample PDF!
According to Cognitive Market Research, epilepsy hold a prominent market share due to the rising prevalence of the condition globally. Additionally, as awareness campaigns drive early diagnosis and treatment initiation, there's a growing demand for anticonvulsant medications like lamotrigine. Furthermore, ongoing research and development efforts to enhance treatment efficacy and safety contribute to market growth. Moreover, the expansion of healthcare infrastructure in developing regions improves access to epilepsy treatment, further boosting sales in this segment.
Bipolar disorder is the fastest-growing category over the forecast period owing to several factors. Firstly, increasing recognition and diagnosis of the disorder contribute to heightened demand for effective mood stabilizers like lamotrigine. Secondly, as mental health awareness campaigns reduce stigma, more individuals seek treatment, expanding the patient pool. Additionally, clinical evidence supporting the efficacy of lamotrigine in bipolar disorder management drives prescription rates. Moreover, ongoing research into new indications and formulations enhances market opportunities for this segment.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, hospital pharmacies held the major market share over the forecast period due to their widespread accessibility and established relationships with healthcare providers. Additionally, hospitals often serve as primary treatment centres for patients with complex medical conditions, including epilepsy and bipolar disorder, driving demand for medications like lamotrigine. Moreover, bulk purchasing by hospitals allows for competitive pricing, further enhancing sales in this segment. Furthermore, the convenience of obtaining prescriptions during hospital visits contributes to sustained market dominance.
Online pharmacies is the fastest-growing category over the forecast period due to several factors. Firstly, the convenience and accessibility of online platforms appeal to patients seeking hassle-free medication procurement. Secondly, the COVID-19 pandemic has accelerated the shift towards online healthcare services, driving adoption of online pharmacies. Additionally, competitive pricing and discounts offered by online platforms attract cost-conscious consumers. Moreover, advancements in telemedicine and e-prescription services streamline the prescription and delivery process, further fuelling growth in this segment.
According to Cognitive Market Research, adults held the major market share over the forecast period due to several factors. Firstly, the prevalence of epilepsy and bipolar disorder is higher among adults compared to other age groups, driving demand for medications like lamotrigine. Additionally, adults often have greater healthcare access and autonomy in treatment decisions, contributing to higher medication adherence rates. Moreover, aging populations globally result in a larger demographic of adults requiring long-term management of chronic conditions, further boosting sales in this segment.
Paediatrics is the fastest-growing category over the forecast period due to various reasons. Firstly, increased awareness and early diagnosis of neurological and mood disorders in children lead to higher prescription rates. Secondly, paediatric formulations and dosing guidelines for lamotrigine have improved, enhancing its suitability for younger patients. Additionally, growing research on the safety and efficacy of lamotrigine in paediatric populations instils confidence among healthcare providers and parents. Moreover, initiatives to address mental health in children and adolescents amplify the demand for treatments like lamotrigine, driving sales in this segment.
Senior Research Analyst at Cognitive Market Research
• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.
Manoj Phagare is a dynamic and results-driven research analyst with a passion for transforming raw data into actionable insights. Armed with a solid foundation in market research and data analysis and working in various domains including chemical & materials and paints & coatings. He thrive on the challenge of uncovering patterns, trends, and opportunities that drive strategic decision-making.His analytical mindset, coupled with effective communication skills, allows him to bridge the gap between data analysis and practical business applications.
In his current role, Manoj is a key player in market research and competitive analysis. He have a proven track record of synthesizing disparate data sources, employing statistical models, and delivering comprehensive insights. He have played a pivotal role in shaping evidence-based strategies that fueled the success of key business initiatives and Collaborating with cross-functional teams.Manoj remains an invaluable asset in the dynamic landscape of market research.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Purity 98%-99%, Purity 99% |
Application | Epilepsy, Bipolar Disorder |
Distribution | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
End User | Paediatrics, Adults |
List of Competitors | Tetrahedron, Polpharma, GlaxoSmithKline, Vignesh Life Sciences, Jubilant, IOL Chemicals and Pharmaceuticals Limited, Veeprho, Smilax |
This chapter will help you gain GLOBAL Market Analysis of Lamotrigine. Further deep in this chapter, you will be able to review Global Lamotrigine Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Lamotrigine. Further deep in this chapter, you will be able to review North America Lamotrigine Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Lamotrigine. Further deep in this chapter, you will be able to review Europe Lamotrigine Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Lamotrigine. Further deep in this chapter, you will be able to review Asia Pacific Lamotrigine Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Lamotrigine. Further deep in this chapter, you will be able to review South America Lamotrigine Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East and Africa Market Analysis of Lamotrigine. Further deep in this chapter, you will be able to review Middle East and Africa Lamotrigine Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
This chapter provides an in-depth analysis of the market share among key competitors of Lamotrigine. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Distribution Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End User Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Lamotrigine market
Chapter 14 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Purity 98%-99% have a significant impact on Lamotrigine market? |
What are the key factors affecting the Purity 98%-99% and Purity 99% of Lamotrigine Market? |
What is the CAGR/Growth Rate of Epilepsy during the forecast period? |
By type, which segment accounted for largest share of the global Lamotrigine Market? |
Which region is expected to dominate the global Lamotrigine Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|